Use access key #2 to skip to page content.
$2.99 0.07 (2.40%)
10/10/2008 4:00 PM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

0

Avatar ocean9643 (< 20) Submitted: 5/15/08 11:16 AM : Outperform Start Price: $3.14 MNKD Score: 32.55

it looks ready to take off

Report this Post Replies: 0 | Reply

Featured Broker Partners